No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2289929 |
chr2:47044218-47044219 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs183861198 |
chr2:47044224-47044225 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs35601954 |
chr2:47044234-47044235 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs549454223 |
chr2:47044244-47044245 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs561253345 |
chr2:47044261-47044262 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs531918913 |
chr2:47044262-47044263 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs140474407 |
chr2:47044263-47044264 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs2289930 |
chr2:47044277-47044278 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs538898424 |
chr2:47044283-47044284 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs547693864 |
chr2:47044297-47044298 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs566453096 |
chr2:47044315-47044316 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs533596748 |
chr2:47044316-47044317 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs555416021 |
chr2:47044321-47044322 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs115839070 |
chr2:47044354-47044355 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs537953500 |
chr2:47044365-47044366 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs11682999 |
chr2:47044381-47044382 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs186267924 |
chr2:47044386-47044387 |
Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs370012546 |
chr2:47044421-47044422 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs149454941 |
chr2:47044443-47044444 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs577923169 |
chr2:47044444-47044445 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs545315155 |
chr2:47044472-47044473 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs75614528 |
chr2:47044481-47044482 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs572383704 |
chr2:47044514-47044515 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs138141127 |
chr2:47044517-47044518 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs561350899 |
chr2:47044525-47044526 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs577524145 |
chr2:47044558-47044559 |
Weak transcription Enhancers Flanking Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs79892725 |
chr2:47044591-47044592 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs117837399 |
chr2:47044596-47044597 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs565094989 |
chr2:47044597-47044598 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs545003914 |
chr2:47044606-47044607 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs532608103 |
chr2:47044613-47044614 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs548065539 |
chr2:47044625-47044626 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs566269090 |
chr2:47044654-47044655 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs190593334 |
chr2:47044655-47044656 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs548666096 |
chr2:47044670-47044671 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs567274248 |
chr2:47044683-47044684 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs182802169 |
chr2:47044684-47044685 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs556336841 |
chr2:47044685-47044686 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs146110667 |
chr2:47044697-47044698 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs564830265 |
chr2:47044712-47044713 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs538867708 |
chr2:47044778-47044779 |
Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs187086274 |
chr2:47044813-47044814 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs554019130 |
chr2:47044814-47044815 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs72804460 |
chr2:47044816-47044817 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs542932110 |
chr2:47044829-47044830 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs554619043 |
chr2:47044844-47044845 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs576036556 |
chr2:47044890-47044891 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs138897271 |
chr2:47044907-47044908 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs540655050 |
chr2:47044916-47044917 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs565083371 |
chr2:47044958-47044959 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|